AlivaMab Discovery Services Announces Planned Leadership Transition | Business Wire
Almirall partners with Ablexis & AlivaMab to accelerate antibody drug discovery - European Pharmaceutical Manufacturer
Ablexis LLC
Larry Green on LinkedIn: Come hear Dana's talk at FoB in October. Stay tuned for even more exciting…
Larry Green on LinkedIn: It's been an exciting and busy year working with our revitalized… | 11 comments
AlivaMab Discovery Services Expands Discovery Agreement with IGM Biosciences | Technology Networks
Antibody Discovery and Development Seminar | Medicine Matters
Ablexis reveals license agreement with Adimab » World Business Outlook
Ablexis licenses antibodies for CAR-T development
AlivaMab Mouse
Almirall alcanza acuerdos con Ablexis y AlivaMab para acelerar el descubrimiento de anticuerpos - Bolsamania.com
AlivaMab Biologics on LinkedIn: AlivaMab Biologics (AMB) is excited to be presenting at the 38th Annual…
Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies
Ablexis and AlivaMab Discovery Services Announce Expansion of Antibody Drug Discovery and Engineering Capabilities AlivaMab Biologics Superior Antibody Therapeutics
Of Mice and mAbs: Dr. Larry Green, Ablexis
Almirall signa acords amb les nord-americanes Ablexis i AlivaMab Discovery Services
Ablexis and AlivaMab Discovery Services
J&J taps AlivaMab for multi-target antibody discovery effort | Fierce Biotech
About - Ablexis Ablexis A superior, next generation transgenic mouse platform for the discovery of therapeutic antibodies
Almirall acelera en el descubrimiento de anticuerpos y firma dos nuevos acuerdos | PlantaDoce
Almirall refuerza su apuesta por el desarrollo de anticuerpos | IM Médico
Technologies AlivaMab Biologics Superior Antibody Therapeutics
